X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE GSK PHARMA TTK HEALTHCARE/
GSK PHARMA
 
P/E (TTM) x 29.2 59.9 48.8% View Chart
P/BV x 5.4 11.7 45.8% View Chart
Dividend Yield % 0.5 2.1 25.7%  

Financials

 TTK HEALTHCARE   GSK PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
GSK PHARMA
Mar-16
TTK HEALTHCARE/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs6633,850 17.2%   
Low Rs3992,966 13.5%   
Sales per share (Unadj.) Rs535.6332.3 161.2%  
Earnings per share (Unadj.) Rs15.944.3 36.0%  
Cash flow per share (Unadj.) Rs20.047.2 42.4%  
Dividends per share (Unadj.) Rs4.0050.00 8.0%  
Dividend yield (eoy) %0.81.5 51.3%  
Book value per share (Unadj.) Rs137.6202.7 67.9%  
Shares outstanding (eoy) m7.7784.70 9.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.010.3 9.7%   
Avg P/E ratio x33.376.9 43.3%  
P/CF ratio (eoy) x26.572.2 36.8%  
Price / Book Value ratio x3.916.8 23.0%  
Dividend payout %25.1112.9 22.2%   
Avg Mkt Cap Rs m4,127288,643 1.4%   
No. of employees `0001.74.6 37.0%   
Total wages/salary Rs m6074,434 13.7%   
Avg. sales/employee Rs Th2,436.76,104.5 39.9%   
Avg. wages/employee Rs Th355.2961.6 36.9%   
Avg. net profit/employee Rs Th72.5813.7 8.9%   
INCOME DATA
Net Sales Rs m4,16228,148 14.8%  
Other income Rs m611,218 5.0%   
Total revenues Rs m4,22329,366 14.4%   
Gross profit Rs m1974,774 4.1%  
Depreciation Rs m32248 12.8%   
Interest Rs m300-   
Profit before tax Rs m1975,744 3.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m026 0.0%   
Tax Rs m732,018 3.6%   
Profit after tax Rs m1243,752 3.3%  
Gross profit margin %4.717.0 27.9%  
Effective tax rate %37.035.1 105.3%   
Net profit margin %3.013.3 22.3%  
BALANCE SHEET DATA
Current assets Rs m1,62921,462 7.6%   
Current liabilities Rs m1,05810,536 10.0%   
Net working cap to sales %13.738.8 35.3%  
Current ratio x1.52.0 75.6%  
Inventory Days Days3068 44.0%  
Debtors Days Days3416 204.6%  
Net fixed assets Rs m5564,717 11.8%   
Share capital Rs m78847 9.2%   
"Free" reserves Rs m87816,308 5.4%   
Net worth Rs m1,06917,171 6.2%   
Long term debt Rs m15916 991.9%   
Total assets Rs m2,39930,620 7.8%  
Interest coverage x7.6NM-  
Debt to equity ratio x0.10 15,928.1%  
Sales to assets ratio x1.70.9 188.7%   
Return on assets %6.412.3 52.3%  
Return on equity %11.621.9 53.0%  
Return on capital %18.533.6 55.0%  
Exports to sales %0.80 5,562.9%   
Imports to sales %1.415.1 9.3%   
Exports (fob) Rs m334 822.5%   
Imports (cif) Rs m584,237 1.4%   
Fx inflow Rs m33519 6.3%   
Fx outflow Rs m638,320 0.8%   
Net fx Rs m-30-7,801 0.4%   
CASH FLOW
From Operations Rs m1271,386 9.1%  
From Investments Rs m-1465,010 -2.9%  
From Financial Activity Rs m22-6,383 -0.3%  
Net Cashflow Rs m312 21.2%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 3.7 10.2 36.3%  
FIIs % 5.2 23.8 21.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 15.4 167.5%  
Shareholders   12,723 102,036 12.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   STRIDES SHASUN LTD  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  ELDER PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 23, 2017 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - DIVIS LABORATORIES COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS